Provided by Tiger Trade Technology Pte. Ltd.

Actuate Therapeutics Inc

0.6102
-0.0688-10.13%
Post-market: 0.62000.0098+1.61%19:26 EDT
Volume:300.99K
Turnover:192.68K
Market Cap:14.60M
PE:-0.69
High:0.6799
Open:0.6410
Low:0.6102
Close:0.6790
52wk High:8.49
52wk Low:0.6042
Shares:23.93M
Float Shares:8.60M
Volume Ratio:0.94
T/O Rate:3.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8859
EPS(LYR):-1.0574
ROE:-553.75%
ROA:-213.40%
PB:14.76
PE(LYR):-0.58

Loading ...

Oct 08, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 06, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Major Issues Report

Form 8-K - Current report
Apr 22, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 21, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 05, 2025

Correspondence

Form CORRESP - Correspondence
Sep 03, 2025

Correspondence

Form CORRESP - Correspondence
Aug 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]